Willy M - Search Results

1

Estimates of acetaminophen (Paracetomal)-associated overdoses in the United States.

Nourjah P, Ahmad SR, Karwoski C, Willy M. Nourjah P, et al. Among authors: willy m. Pharmacoepidemiol Drug Saf. 2006 Jun;15(6):398-405. doi: 10.1002/pds.1191. Pharmacoepidemiol Drug Saf. 2006. PMID: 16294364

2

Antidepressant medication use and risk of persistent pulmonary hypertension of the newborn.

Andrade SE, McPhillips H, Loren D, Raebel MA, Lane K, Livingston J, Boudreau DM, Smith DH, Davis RL, Willy ME, Platt R. Andrade SE, et al. Among authors: willy me. Pharmacoepidemiol Drug Saf. 2009 Mar;18(3):246-52. doi: 10.1002/pds.1710. Pharmacoepidemiol Drug Saf. 2009. PMID: 19148882

3

Emergency department visits attributed to selected analgesics, United States, 2004-2005.

Willy M, Kelly JP, Nourjah P, Kaufman DW, Budnitz DS, Staffa J. Willy M, et al. Pharmacoepidemiol Drug Saf. 2009 Mar;18(3):188-95. doi: 10.1002/pds.1691. Pharmacoepidemiol Drug Saf. 2009. PMID: 19116955

4

Informatic tools and approaches in postmarketing pharmacovigilance used by FDA.

Weaver J, Willy M, Avigan M. Weaver J, et al. Among authors: willy m. AAPS J. 2008;10(1):35-41. doi: 10.1208/s12248-007-9004-5. Epub 2008 Jan 25. AAPS J. 2008. PMID: 18446503 Free PMC article. Review.

5

Suicidal adverse events in pediatric randomized, controlled clinical trials of antidepressant drugs are associated with active drug treatment: a meta-analysis.

Mosholder AD, Willy M. Mosholder AD, et al. Among authors: willy m. J Child Adolesc Psychopharmacol. 2006 Feb-Apr;16(1-2):25-32. doi: 10.1089/cap.2006.16.25. J Child Adolesc Psychopharmacol. 2006. PMID: 16553526

6

Characterization of acetaminophen overdose-related emergency department visits and hospitalizations in the United States.

Manthripragada AD, Zhou EH, Budnitz DS, Lovegrove MC, Willy ME. Manthripragada AD, et al. Among authors: willy me. Pharmacoepidemiol Drug Saf. 2011 Aug;20(8):819-26. doi: 10.1002/pds.2090. Epub 2011 Feb 3. Pharmacoepidemiol Drug Saf. 2011. PMID: 21294217

7

Trends in rates of acetaminophen-related adverse events in the United States.

Major JM, Zhou EH, Wong HL, Trinidad JP, Pham TM, Mehta H, Ding Y, Staffa JA, Iyasu S, Wang C, Willy ME. Major JM, et al. Among authors: willy me. Pharmacoepidemiol Drug Saf. 2016 May;25(5):590-8. doi: 10.1002/pds.3906. Epub 2015 Nov 3. Pharmacoepidemiol Drug Saf. 2016. PMID: 26530380 Free PMC article.

8

What is prescription labeling communicating to doctors about hepatotoxic drugs? A study of FDA approved product labeling.

Willy ME, Li Z. Willy ME, et al. Pharmacoepidemiol Drug Saf. 2004 Apr;13(4):201-6. doi: 10.1002/pds.856. Pharmacoepidemiol Drug Saf. 2004. PMID: 15255086

9

Drug-risk communication to pharmacists: assessing the impact of risk-minimization strategies on the practice of pharmacy.

Lee LY, Kortepeter CM, Willy ME, Nourjah P. Lee LY, et al. Among authors: willy me. J Am Pharm Assoc (2003). 2008 Jul-Aug;48(4):494-500. doi: 10.1331/JAPhA.2008.07045. J Am Pharm Assoc (2003). 2008. PMID: 18653425

10

Candidate metrics for evaluating the impact of prescriber education on the safe use of extended-release/long-acting (ER/LA) opioid analgesics.

Willy ME, Graham DJ, Racoosin JA, Gill R, Kropp GF, Young J, Yang J, Choi J, MaCurdy TE, Worrall C, Kelman JA. Willy ME, et al. Pain Med. 2014 Sep;15(9):1558-68. doi: 10.1111/pme.12459. Epub 2014 May 15. Pain Med. 2014. PMID: 24828968

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results